Back to Newsroom

Curis Announces Presentation of Data From CUDC-427 and IRAK-4 Programs at AACR Annual Meeting

LEXINGTON, Mass., April 14, 2015 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today announced that Curis scientists and its collaborator, Aurigene Discovery Technologies Limited, will present data from two programs at the Annual Meeting of American Association of Cancer Research (AACR) to be held April 18 – 22, 2015 in Philadelphia.

Click here to read more